People: Broadcom Corp (BRCM.O)

BRCM.O on Nasdaq

29.54USD
9 Feb 2010
Price Change (% chg)

$0.74 (+2.57%)
Prev Close
$29.54
Open
--
Day's High
$29.79
Day's Low
$28.99
Volume
11,622,598
Avg. Vol
12,774,586
52-wk High
$32.49
52-wk Low
$15.31

view people for:

Brandt, Eric 

Brief Biography

Mr. Eric K. Brandt joined Broadcom Corporation as Senior Vice President and Chief Financial Officer in March 2007. He also serves as a director and officer of certain Broadcom subsidiaries. From September 2005 until March 2007, Mr. Brandt served as President and Chief Executive Officer of Avanir Pharmaceuticals. Prior to Avanir, Mr. Brandt was Executive Vice President — Finance and Technical Operations, Chief Financial Officer of Allergan, Inc., a global specialty pharmaceutical company, where he also held a number of other senior positions after joining Allergan in 1999. Previously, Mr. Brandt spent 10 years with The Boston Consulting Group, a privately-held global business consulting firm, most recently serving as Vice President and Partner and as a senior member of the firm’s heath care practice. In addition, while at BCG he led the North American operations practice and had experience advising computer and telecommunications clients. He is also a director of Dentsply International, Inc., a dental products company, and Vertex Pharmaceuticals, Inc., a global biotechnology company, where he chairs the audit committee. Mr. Brandt received a B.S. in Chemical Engineering from the Massachusetts Institute of Technology and an M.B.A. from Harvard Business School.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
660,154 -- 659,165 2,211,060

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total
Major, John --
McGregor, Scott 10,822,900
Brandt, Eric 2,211,060
Ramaswami, Rajiv --
Chong, Arthur 377,489
Lagatta, Thomas 1,771,790
As Of 30 Dec 2008
view people for: